Propanc Biopharma, Inc.
	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014	Q4-CY2013
Balance Sheet Date			2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31	2023-Sep-30	2023-Jun-30	2023-Mar-31	2022-Dec-31	2022-Sep-30	2022-Jun-30	2022-Mar-31	2021-Dec-31	2021-Sep-30	2021-Jun-30	2021-Mar-31	2020-Dec-31	2020-Sep-30	2020-Jun-30	2020-Mar-31	2019-Dec-31	2019-Sep-30	2019-Jun-30	2019-Mar-31	2018-Dec-31	2018-Sep-30	2018-Jun-30	2018-Mar-31	2017-Dec-31	2017-Sep-30	2017-Jun-30	2017-Mar-31	2016-Dec-31	2016-Sep-30	2016-Jun-30	2016-Mar-31	2015-Dec-31	2015-Sep-30	2015-Jun-30	2015-Mar-31	2014-Dec-31	2014-Sep-30	2014-Jun-30	2014-Mar-31	2013-Dec-31
Fiscal Period			Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024	Q2-FY2024	Q1-FY2024	Q4-FY2023	Q3-FY2023	Q2-FY2023	Q1-FY2023	Q4-FY2022	Q3-FY2022	Q2-FY2022	Q1-FY2022	Q4-FY2021	Q3-FY2021	Q2-FY2021	Q1-FY2021	Q4-FY2020	Q3-FY2020	Q2-FY2020	Q1-FY2020	Q4-FY2019	Q3-FY2019	Q2-FY2019	Q1-FY2019	Q4-FY2018	Q3-FY2018	Q2-FY2018	Q1-FY2018	Q4-FY2017	Q3-FY2017	Q2-FY2017	Q1-FY2017	Q4-FY2016	Q3-FY2016	Q2-FY2016	Q1-FY2016	Q4-FY2015	Q3-FY2015	Q2-FY2015	Q1-FY2015	Q4-FY2014	Q3-FY2014	Q2-FY2014
Total Revenue				5,400,000$
Cost Of Revenue				0$																			(25,815$)	7,591$	7,592$	10,632$	6,287$	7,248$	6,449$	8,078$	6,787$	8,005$	6,899$	8,830$
Gross Profit				5,400,000$																			83,451$	(7,591$)	(7,592$)	(10,632$)	(6,287$)	(7,248$)	(6,449$)	(8,078$)	(6,787$)	(8,005$)	(6,899$)	(8,830$)
Gross Margin				100.00%
Operating Expenses			3,638,873$	53,122,244$	207,981$	282,473$	245,333$	414,289$	432,207$	410,070$	203,005$	377,844$	600,498$	566,457$	593,269$	494,024$	396,917$	478,294$	725,009$	418,721$	266,344$	373,957$	587,080$	599,577$	1,376,008$	898,786$	830,044$	564,477$	751,371$	440,793$	504,966$	799,130$	1,430,171$	1,195,145$	1,102,777$	1,539,628$	1,903,095$	1,165,700$	3,446,102$	1,285,517$	1,138,932$	1,002,453$	701,443$	514,199$	246,874$	235,361$	120,084$	101,626$	222,671$
Operating Income			(3,645,246$)	(47,722,244$)	(213,382$)	(290,790$)	(259,899$)	(420,867$)	(438,064$)	(417,219$)	(209,602$)	(386,209$)	(608,004$)	(572,830$)	(599,192$)	(502,181$)	(403,467$)	(486,030$)	(726,936$)	(427,952$)	(274,094$)	(383,161$)	(594,074$)	(607,168$)	(1,383,600$)	(909,418$)	(836,331$)	(571,725$)	(757,820$)	(448,871$)	(511,753$)	(807,135$)	(1,437,070$)	(1,203,975$)	(1,109,532$)	(1,547,277$)	(1,909,086$)	(1,174,297$)	(3,455,590$)	(1,290,752$)	(1,143,821$)	(1,007,391$)	(701,443$)	(516,565$)	(249,441$)	(238,138$)	(122,883$)	(104,315$)	(225,454$)
Other Income			(426,215$)	(6,345,102$)	(216,801$)	(63,520$)	(98,916$)	27,033$	(10,478$)	244,587$	(423,004$)	(268,108$)	91,884$	118,285$	(191,635$)	207,082$	(274,068$)	105,225$	(23,783$)	838$	28,285$	116,897$	2,039,869$	(1,620,144$)	(37,287$)	(16,194$)	(759,200$)	180,402$	(314,222$)	(1,051,531$)	(330,123$)	146,540$	(458,472$)	172,636$	153,901$	667,705$	(596,205$)	543,707$	2,404,532$	243,188$	(1,334,601$)	585,114$	(647,369$)	261,589$	(78,302$)	3,314$	(44,124$)	57,351$	223,627$
Interest Income														2$					0$	0$	1$		803$	137$	3$	3$	2$	2$	23$	4$	5$	15$	39$	28$	24$	648$	5$	8$	0$	0$	0$	2,027$	17$	13$	0$	3$	18$	0$	0$
Interest Expenses								133,141$	264,462$	178,234$	114,242$	157,208$	98,619$	162,752$	113,665$	167,375$	177,905$	109,853$	29,440$	102,901$	157,835$	159,281$	242,270$	384,804$	446,082$	675,225$	5,203$	189,809$	494,989$	624,538$	579,099$	830,911$	486,754$	892,432$	677,399$	798,361$	1,255,627$	471,387$	1,806,992$	1,104,315$	1,155,645$	418,644$	475,960$	199,287$	100,176$	548,479$	50,856$	19,901$	20,225$
Income Before Tax			(4,071,461$)	(54,067,346$)	(430,183$)	(354,310$)	(358,815$)	(526,975$)	(713,004$)	(350,866$)	(746,848$)	(811,525$)	(614,739$)	(617,295$)	(904,492$)	(462,474$)	(855,440$)	(490,658$)	(780,159$)	(530,015$)	(403,643$)	(425,545$)	1,204,328$	(2,611,979$)	(1,866,966$)	(1,600,834$)	(1,600,732$)	(581,130$)	(1,567,008$)	(2,124,936$)	(1,420,970$)	(1,491,491$)	(2,382,257$)	(1,923,743$)	(1,633,006$)	(1,677,285$)	(3,760,913$)	(1,101,969$)	(2,858,050$)	(2,151,879$)	(3,634,067$)	(838,894$)	(1,824,755$)	(454,250$)	(427,919$)	(783,300$)	(217,845$)	(66,865$)	(22,052$)
Tax Expenses							(237$)	(275$)	(128,620$)		1,196$	(1,716$)	(129,321$)		273$	213$	(55,463$)		(1,138$)	(112,277$)			340$	(26,317$)	143$	(108,894$)	807$	726$	(116,970$)		1,457$	(485$)	(180,278$)		486$	(306,159$)	0$	0$	(568$)	30$	(72,000$)	0$	1,832$	0$	(82,440$)	0$	(258$)	0$	(48,451$)
Income from Continuing Operations			(4,071,461$)	(54,067,346$)	(430,183$)	(354,310$)	(358,578$)	(526,700$)	(584,384$)	(350,866$)	(748,044$)	(809,809$)	(485,418$)	(617,295$)	(904,765$)	(462,687$)	(799,977$)	(490,658$)	(779,021$)	(417,738$)	(403,643$)	(425,545$)	1,203,988$	(2,585,662$)	(1,867,109$)	(1,491,940$)	(1,601,539$)	(581,856$)	(1,450,038$)	(2,124,936$)	(1,422,427$)	(1,491,006$)	(2,201,979$)	(1,923,743$)	(1,633,492$)	(1,371,126$)	(3,760,913$)	(1,101,969$)	(2,857,482$)	(2,151,909$)	(3,562,067$)	(838,894$)	(1,826,587$)	(454,250$)	(345,479$)	(783,300$)	(217,587$)	(66,865$)	26,399$
Income from Discontinued Operations
Consolidated Income			(4,071,461$)	(54,067,346$)	(430,183$)	(354,310$)	(358,578$)	(526,700$)	(584,384$)	(350,866$)	(748,044$)	(809,809$)	(485,418$)	(617,295$)	(904,765$)	(462,687$)	(799,977$)	(490,658$)	(779,021$)	(417,738$)	(403,643$)	(425,545$)	1,203,988$	(2,585,662$)	(1,867,109$)	(1,491,940$)	(1,601,539$)	(581,856$)	(1,450,038$)	(2,124,936$)	(1,422,427$)	(1,491,006$)	(2,201,979$)	(1,923,743$)	(1,633,492$)	(1,371,126$)	(3,760,913$)	(1,101,969$)	(2,857,482$)	(2,151,909$)	(3,562,067$)	(838,894$)	(1,826,587$)	(454,250$)	(345,479$)	(783,300$)	(217,587$)	(66,865$)	26,399$
Net Income			(4,071,461$)	(54,067,346$)	(430,183$)	(354,310$)	(358,578$)	(526,700$)	(584,384$)	(350,866$)	(748,044$)	(809,809$)	(485,418$)	(617,295$)	(904,765$)	(462,687$)	(799,977$)	(490,658$)	(779,021$)	(417,738$)	(403,643$)	(425,545$)	1,203,988$	(2,585,662$)	(1,867,109$)	(1,491,940$)	(1,601,539$)	(581,856$)	(1,450,038$)	(2,124,936$)	(1,422,427$)	(1,491,006$)	(2,201,979$)	(1,923,743$)	(1,633,492$)	(1,371,126$)	(3,760,913$)	(1,101,969$)	(2,857,482$)	(2,151,909$)	(3,562,067$)	(838,894$)	(1,826,587$)	(454,250$)	(345,479$)	(783,300$)	(217,587$)	(66,865$)	26,399$
Profit Margin				(1,001.25%)
Earnings to Minority
Earnings to Common Shareholders			(4,071,461$)	(54,067,346$)	(430,183$)	(354,310$)	(358,578$)	(542,500$)	(618,969$)	(493,441$)	(805,760$)	(809,809$)	(504,740$)	(1,006,530$)	(1,159,474$)	(700,076$)	(893,375$)	(605,502$)	(1,170,770$)	(417,738$)	(403,643$)	(425,545$)	1,203,988$	(2,585,662$)	(1,867,109$)	(1,491,940$)	(1,601,539$)	(581,856$)	(1,450,038$)	(2,124,936$)	(1,422,427$)	(1,491,006$)	(2,201,979$)	(1,923,743$)	(1,633,492$)	(1,371,126$)	(3,760,913$)	(1,101,969$)	(2,857,482$)	(2,151,909$)	(3,562,067$)	(838,894$)	(1,826,587$)	(454,250$)	(345,479$)	(783,300$)	(217,587$)	(66,865$)	26,399$
Earnings Per Share, Basic			0.01$	(12.50$)	(32.23$)	0.00$	0.03$	(545.77$)	(1,559.12$)	(0.04$)	(0.22$)	(0.42$)	(0.53$)	(2.13$)	0.01$	(0.01$)	(0.02$)	(0.02$)	(0.16$)	(0.12$)	(0.45$)	(0.71$)	(1.25$)	(348.75$)	(1,250.58$)	(1.41$)	(1.35$)	(0.89$)	(41.33$)	(9.45$)	0.04$	(0.06$)	(0.20$)	(0.36$)	(0.41$)	(0.38$)	(1.13$)	(0.36$)	0.00$	(1.05$)	(0.01$)	0.00$	(0.01$)	0.00$	0.00$	(0.01$)	0.00$	0.00$	0.00$
Earnings Per Share, Diluted			0.01$	(12.50$)	(32.23$)	0.00$	0.03$	(545.77$)	(1,559.12$)	(0.04$)	(0.22$)	(0.42$)	(0.53$)	(2.13$)			(0.02$)	(0.02$)	(0.16$)	(0.12$)	(0.45$)	(0.71$)	(1.25$)	(348.75$)	(1,250.58$)	(1.41$)	(1.35$)	(0.89$)	(41.33$)	(9.45$)	0.04$	(0.06$)	(0.20$)	(0.36$)	(0.41$)	(0.38$)	(1.13$)	(0.36$)	0.00$	(1.05$)	(0.01$)	0.00$	(0.01$)	0.00$	0.00$	(0.01$)	0.00$	0.00$	0.00$
Average Shares, Basic			-579,404,135	4,325,994	13,347	590,937,498	-10,985,404	994	397	10,989,681	3,597,074	1,924,074	960,471	473,589	-142,597,089	66,353,881	49,373,565	27,142,519	7,179,698	3,452,810	900,626	597,314	-964,804	7,414	1,493	1,054,433	1,189,197	650,513	35,081	224,965	-39,510,299	23,426,370	10,955,901	5,285,552	3,984,705	3,653,154	3,327,023	3,069,246	-744,301,390	2,043,235	399,822,354	350,228,617	337,456,752	201,772,426	95,007,061	76,297,745	72,688,867	72,684,768	72,385,909
Average Shares, Diluted			-579,404,135	4,325,994	13,347	590,937,498	-10,985,404	994	397	10,989,681	3,597,074	1,924,074	960,471	473,589			49,373,565	27,142,519	7,179,698	3,452,810	900,626	597,314	-964,804	7,414	1,493	1,054,433	1,189,197	650,513	35,081	224,965	-39,510,299	23,426,370	10,955,901	5,285,552	3,984,705	3,653,154	3,327,023	3,069,246	-744,301,390	2,043,235	399,822,354	350,228,617	337,456,752	201,772,426	95,007,061	76,297,745	72,688,867	72,684,768	72,385,909
EBIT			(4,071,461$)	(54,067,346$)	(430,183$)	(354,310$)	(358,815$)	(393,834$)	(448,542$)	(172,632$)	(632,606$)	(654,317$)	(516,120$)	(454,543$)	(790,827$)	(295,099$)	(677,535$)	(380,805$)	(750,719$)	(427,114$)	(245,808$)	(266,264$)	1,446,598$	(2,227,175$)	(1,420,884$)	(925,609$)	(1,595,529$)	(391,321$)	(1,072,019$)	(1,500,398$)	(841,871$)	(660,580$)	(1,895,503$)	(1,031,311$)	(955,607$)	(878,924$)	(2,505,286$)	(630,582$)	(1,051,058$)	(1,047,564$)	(2,478,422$)	(420,250$)	(1,348,795$)	(254,963$)	(327,743$)	(234,821$)	(166,989$)	(46,964$)	(1,827$)
EBITDA			(4,071,461$)	(54,067,346$)	(430,183$)	(354,310$)	(358,815$)	(393,834$)	(448,542$)	(172,632$)	(632,606$)	(654,317$)	(516,120$)	(454,543$)	(790,827$)	(295,099$)	(677,535$)	(380,805$)	(750,719$)	(427,114$)	(245,808$)	(266,264$)	1,446,598$	(2,227,175$)	(1,420,884$)	(925,609$)	(1,595,529$)	(391,321$)	(1,072,019$)	(1,500,398$)	(841,871$)	(660,580$)	(1,895,503$)	(1,031,311$)	(955,607$)	(878,924$)	(2,505,286$)	(630,582$)	(1,051,058$)	(1,047,564$)	(2,478,422$)	(420,250$)	(1,348,795$)	(254,963$)	(327,743$)	(234,821$)	(166,989$)	(46,964$)	(1,827$)

• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation